First Wave Stock Forecast - Price Action Indicator

FWBIDelisted Stock  USD 0.61  0.03  4.69%   
First Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of First Wave's historical fundamentals, such as revenue growth or operating cash flow patterns.
  
First Wave BioPharma has current Price Action Indicator of (0.03). Price Action indicator evaluates an asset for a given trading period using the following formula: ((close - open) + (close - high) + (close - low)) / 2. This indicator is consistent with the interpretation of Japanese candlestick patterns.
Check First Wave VolatilityBacktest First WaveInformation Ratio  

First Wave Trading Date Momentum

On November 23 2024 First Wave BioPharma was traded for  0.61  at the closing time. The top price for the day was 0.66  and the lowest listed price was  0.59 . There was no trading activity during the period 0.0. Lack of trading volume on November 23, 2024 did not affect price variability. The overall trading delta against the current closing price is 4.92% .
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
Compare First Wave to competition

View First Wave Related Equities

 Risk & Return  Correlation

First Wave Market Strength Events

Market strength indicators help investors to evaluate how First Wave stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading First Wave shares will generate the highest return on investment. By undertsting and applying First Wave stock market strength indicators, traders can identify First Wave BioPharma entry and exit signals to maximize returns.

First Wave Risk Indicators

The analysis of First Wave's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in First Wave's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting first stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Currently Active Assets on Macroaxis

Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Other Consideration for investing in First Stock

If you are still planning to invest in First Wave BioPharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the First Wave's history and understand the potential risks before investing.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Valuation
Check real value of public entities based on technical and fundamental data
Volatility Analysis
Get historical volatility and risk analysis based on latest market data